NSEInvestor Presentation4d ago · 3 Nov 2026, 02:58 pm
Investor Presentation
Bodal Chemicals Limited · BODALCHEM
✦ AI Summary▲ PositiveResults
Bodal Chemicals Limited has informed the Exchange about Investor Presentation, highlighting Q2 & H1FY27 financial performance with 67% revenue growth, 114% EBITDA growth, and 1259% net profit growth.
Analysis Scores
Earnings Impact8/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact9/10
Market Sentiment8/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Bodal Chemicals Limited has informed the Exchange about Investor Presentation
Attachments (1)
📄pdf
Download →
BODALCHEM_03112026145812_Bodal_Chem_03_11_2026_Presentation.pdf
View document text
By Online Submission
Sec/26-27/89
Date: 03-11-2026
To, The General Manager,
The General Manager, National Stock Exchange of India Ltd.
BSE Ltd. Exchange Plaza,
1st Floor, New Trading Ring, Plot no. C/1, G Block,
Rotunda Building, P.J. Tower, Bandra-Kurla Complex
Dalal Street, Fort Bandra (E), Mumbai - 400 051.
Mumbai- 400 001 NSE CODE: BODALCHEM
BSE Code: 524370
Dear Sir/Madam,
SUB: Earning/Investor Presentation- November 2026
Ref: Regulation 30, Schedule III Part A of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015.
With reference to the above captioned subject, we herewith enclosed Earning/Investor Presentation-
November 2026
This is for your information and record please.
Thanking You,
For, BODAL CHEMICALS LTD.
Ashutosh Bhatt
Company Secretary
Encl: As Above
Bodal Chemicals Limited
Investor Presentation-November 2026
Safe Harbour
This presentation and the accompanying slides (the “Presentation”), which have been prepared by Bodal Chemicals Limited (the “Company”), have been
prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and
shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will
be made except by means of a statutory offering document containing detailed information about the Company.
This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no
representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and
reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may
consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded.
This presentation contains certain forward looking statements concerning the Company’s future business prospects and business profitability, which are
subject to a number of risks and uncertainties and the actual results could materially differ from those in such forward looking statements. The risks and
uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in earnings, our ability to manage
growth, competition (both domestic and international), economic growth in India and abroad, ability to attract and retain highly skilled professionals,
time and cost over runs on contracts, our ability to manage our international operations, government policies and actions regulations, interest and other
fiscal costs generally prevailing in the economy. The Company does not undertake to make any announcement in case any of these forward looking
statements become materially incorrect in future or update any forward looking statements made from time to time by or on behalf of the Company.
Q2 & H1FY27 Highlights
Business Highlights
Revenue EBITDA PAT
H1FY27 Rs 15,991 mn H1FY27 Rs. 2,027 mn H1FY27 Rs. 1,118 mn
Q2FY27 Rs. 8,840 mn Q2FY27 Rs. 1,276 mn Q2FY27 Rs. 814 mn
• During the H1FY27, Company achieved all time high total revenue of Rs 15,991 mn, 67% growth on YoY basis. This growth is led by better realization
and improved volume across the divisions. The robust margin of key dyes intermediates and with effective pass through of higher raw material cost, the
company has achieved highest absolute EBITDA of Rs. 2027 mn, remarkable 114% growth on YoY for the 1st half of current year. During Q2 Company
achieved Total revenue at Rs. 8840 mn, 77 % growth on YoY basis. EBITDA stood at Rs.1276 mn, 197% growth on YoY basis with margin of 14%. Net
Profit stood at Rs. 814 mn,1259% growth on YoY basis.
• During the H1FY27, revenue from Dye intermediates grew by 68% led by volume with outstanding margin. Dyestuff grew by 42%, this improved
realization helped to absorb raw material pressure and Basic Chemicals, grew by 136% YoY mainly due to increase in the prices of main raw material i.e.
Sulphur. In Q2FY27, Revenue from Dye Intermediates stood at Rs.3,449 mn, grew by 88% quarterly on YoY basis, Revenue from Basic Chemicals Stood at
Rs.990 mn, grew by 199% quarterly on YoY basis, Revenue from Dyestuffs stood at Rs.2,115 mn, grew by 60% quarterly on YoY basis.
• During the H1FY27, revenue from Chlor Alkali business has grew by 6% on YoY basis, led by comparative better realization on YoY basis. In Q2FY27
Revenue from Chlor Alkali business stood at 908 mn, grew by 8% quarterly on YoY basis.
• During the H1FY27, in Saykha’s the Benzene downstream products division has started contributing to the topline. Recent better realization and
improved volume will lead to meaningful contribution on a quarter on quarter basis.
• The Sener Boya- Turkish, Chinese and BCTPL subsidiaries have performed overall satisfactory during the Q2FY27.
• Driven by an outstanding performance in our dyes intermediates division, higher volumes across the divisions, effective raw material cost pass-through,
and integrated manufacturing capacity, we delivered record-high quarterly revenue and earnings. We anticipate that due to structural changes in China
and stabilization of Benzene downstream products plant, better run should continue for the company in coming quarters.
* On Consolidated basis 4
Performance Highlights
Revenue (Rs. In Mn) EBITDA (Rs. In Mn) PAT (Rs. In Mn)
8.6% Q142.4F%Y26 1.2% 9.2% Margin
8,840
Q2 FY27 1,276 814
5,004
Performance
Q2FY26 Q2FY27 Q2FY26 Q2FY27 Q2FY26 Q2FY27
9.9% 12.7% 1.6% 7.0%
15,991
H1FY27 2,027
1,118
Performance
9,586
H1FY26 H1FY27 H1FY26 H1FY27 H1FY26 H1FY27
* On Consolidated basis 5
Performance Highlights
H1 FY26 H1 FY27
Revenue Rs 9,166 mn Revenue Rs 15,442 mn
9% 8% 12%
17% Basic Chemicals
Dyestuff
18% Dye Intermediates
Caustic Soda
Others
Domestc
Export
pukaerB
euneveR
pukaerB
cihpargoeG
* On Consolidated basis –Sales of products excluding other non operating income
Performance Highlights
Basic Chemicals Dyestuff Dye Intermediates Chlor Alkali^
5,615
1,828 3,605
2,538 3,449 3,336
2,115
1,322 1,834
Q2’26 Q2’27 H1’26 H1’27
pukaerB
euneveR
emuloV
noitcudorP
(Rs in mn)
1,778
1,682
841 908
Q2’26 Q2’27 H1’26 H1’27 Q2’26 Q2’27 H1’26 H1’27 Q2’26 Q2’27 H1’26 H1’27
*Revenue breakup on a Consolidated basis
(MT)
9056
16956
115248 113312 7834 14727 40889
38886
5314
58517 58343 4093 7835 8830 20332 20123
Q2’26 Q2’27 H1’26 H1’27 Q2’26 Q2’27 H1’26 H1’27 Q2’26 Q2’27 H1’26 H1’27 Q2’26 Q2’27 H1’26 H1’27
* Production Volume on a Standalone basis due to limited information on subsidiaries ^Production volume - Caustic Soda only
Subsidiaries Performance
(Rs in mn)
BCTPL Sen-er Boya BCL China
165% -25% 27%
74 51
Q2FY26 Q2FY27
euneveR
BCL Indonesia
-62%
Q2FY26 Q2FY27 Q2FY26 Q2FY27 Q2FY26 Q2FY27
Particulars BCTPL Sener Boya Bodal-China Bodal-Indonesia
(Rs in mn) Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27 Q2 FY26 Q2 FY27
Sales
27.8 73.7 75.7 56.8 40.3 51.0 20.2 7.7
1.6 1.7 -11.9 4.6 9.5 4.4 5.2 -1.4
1.2 1.3 5.6 14.1 9.4 4.5 5.2 -1.4
Consolidated Profit & Loss Statement
Particulars (Rs. In Mn) Q2 FY27 Q2 FY26 Y-o-Y% H1 FY27 H1 FY26 Y-o-Y%
Revenue from Operation 8,633.7 4,804.5 15,724.2 9,346.6
Other Income 205.9 199.3 267.3 239.8
Total Revenue 8,839.6 5,003.8 76.7% 15,991.5 9,586.3 66.8%
Raw Material Consumed 5,126.5 2,741.2 9,388.3 5,116.5
Employee Expenses 400.7 321.4 728.1 636.8
Other Expenses 2,023.9 1,493.2 3,822.3 2,854.0
Loss arising from Company's Subsidiary operating
12.7 18.9 25.8 33.3
in hyperinflationary economies
EBITDA 1,275.9 429.1 197.3% 2,026.9 945.7 114.3%
EBITDA (%) 14.4% 8.6% 12.7% 9.9%
Depreciation 177.6 174.2 351.7 349.2
EBIT 1098.3 255.0 1675.2 596.5
EBIT (%) 12.4% 5.1% 10.5% 6.2%
Finance Cost 198.3 199.2 384.0 415.5
Exceptional Items 0.0 0.3 0.0 0.3
Profit Before Tax 900.0 55.5 1,291.2 180.7
Tax 85.5 -4.4 172.9 25.5
Profit After Tax
[Showing first 8,000 characters — download PDF for full document]